share_log

Atavistik Bio Has Entered Into A Research Collaboration With Pfizer For Precision Allosteric Therapeutics, Leveraging Atavistik Bio's Platform To Identify And Validate Allosteric Binders Against Two Undisclosed, Pfizer-designated Targets, Financial...

Atavistik Bio Has Entered Into A Research Collaboration With Pfizer For Precision Allosteric Therapeutics, Leveraging Atavistik Bio's Platform To Identify And Validate Allosteric Binders Against Two Undisclosed, Pfizer-designated Targets, Financial...

Atavistik Bio與輝瑞達成了一項研究合作,旨在利用Atavistik Bio的平台識別和驗證針對兩個未披露的輝瑞指定靶點的精確變構治療藥物。
Benzinga ·  01/02 20:05

Atavistik Bio Has Entered Into A Research Collaboration With Pfizer For Precision Allosteric Therapeutics, Leveraging Atavistik Bio's Platform To Identify And Validate Allosteric Binders Against Two Undisclosed, Pfizer-designated Targets, Financial Terms Were Not Disclosed

Atavistik Bio已與輝瑞達成研究合作,針對精確的變構療法,利用Atavistik Bio的平台識別和驗證針對兩個未公開的輝瑞指定目標的變構結合劑,財務條款未透露。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論